Quality of Life and Economic Burden of Respiratory Disease in Asia-Pacific-Asia-Pacific Burden of Respiratory Diseases Study

Value in Health Regional Issues

Volumn 9, Issue , 2016, Pages 72-77

  Wang, De Yun ^a   Ghoshal, Aloke Gopal ^b   Bin Abdul Muttalif, Abdul Razak ^c   Lin, Horng Chyuan ^d   Thanaviratananich, Sanguansak ^e   Bagga, Shalini ^f   Faruqi, Rab ^f   Sajjan, Shiva ^f   Brnabic, Alan J M ^g   Dehle, Francis C ^g   Cho, Sang Heon ^h  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b National Allergy Asthma and Bronchitis Institute   (India)

^c Institute of Respiratory Medicine   (Malaysia)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e KHON KAEN UNIVERSITY   (Thailand)

^f MERCK RESEARCH LABORATORIES   (United States)

^g OPTUM   (United States)

^h Seoul National University Hospital   (South Korea)

Author keywords

Allergic rhinitis; Asthma; COPD; Cost of illness; Health care costs; Quality of life; Respiratory disorders; Rhinosinusitis

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; ASIA PACIFIC REGION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST OF ILLNESS; CROSS-SECTIONAL STUDY; GEOGRAPHIC NAMES; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; RHINOSINUSITIS; ADOLESCENT; ASIA; BREATHING DISORDER; COMPLICATION; ECONOMICS;

ADOLESCENT; ASIA; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; HUMANS; QUALITY OF LIFE; RESPIRATION DISORDERS;

EID: 84957081881     PISSN: 22121099     EISSN: 22121102     Source Type: Journal    
DOI: 10.1016/j.vhri.2015.11.004     Document Type: Article

References (26)

1. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive report 2007, World Health Organization, World Health Organization, Geneva, Switzerland.
2. Bahadori K., Doyle-Waters M.M., Marra C., et al. Economic burden of asthma: a systematic review. BMC Pulm Med 2009, 9:24.
3. Bhattacharyya N. Contemporary assessment of the disease burden of sinusitis. Am J Rhinol Allergy 2009, 23:392-395.
4. Bhattacharyya N. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States. Laryngoscope 2011, 121:1830-1833.
5. Wouters E.F. Economic analysis of the confronting COPD survey: an overview of results. Respir Med 2003, 97:S3-14.
6. Schramm B., Ehlken B., Smala A., et al. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 2003, 21:116-122.
7. Bhattacharyya N. The economic burden and symptom manifestations of chronic rhinosinusitis. Am J Rhinol 2003, 17:27-32.
8. Stahl E., Lindberg A., Jansson S.A., et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 2005, 3:56.
9. Chen H., Gould M.K., Blanc P.D., et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007, 120:396-402.
10. Meltzer E.O. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001, 108:S45-S53.
11. Reilly M.C., Zbrozek A.S., Dukes E.M. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993, 4:353-365.
12. Ware J.E., Kosinski M., Keller S.D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
13. Juniper E.F., Guyatt G.H., Cox F.M., et al. Development and validation of the mini asthma quality of life questionnaire. Eur Respir J 1999, 14:32-38.
14. Jones P.W., Harding G., Berry P., et al. Development and first validation of the COPD assessment test. Eur Respir J 2009, 34:648-654.
15. Piccirillo J.F., Merritt M.G., Richards M.L. Psychometric and clinimetric validity of the 20-item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg 2002, 126:41-47.
16. Lai C.K.W., Kim Y.Y., Kuo S.H., et al. Cost of asthma in the Asia-Pacific region. Eur Respir Rev 2006, 15:10-16.
17. International Labour Organization.ILO Global Wage Database.Geneva, Switzerland : International Labour Organization ,2012.
18. Teo W.S., Tan W.S., Chong W.F., et al. Economic burden of chronic obstructive pulmonary disease. Respirology 2012, 17:120-126.
19. Chiang C.H. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan. Respirology 2008, 13:689-694.
20. Reilly M.C., Tanner A., Meltzer E.O. Work, classroom and activity impairment instruments: validation studies in allergic rhinitis. Clin Drug Investig 1996, 11:278-288.
21. Demoly P., Gueron B., Annunziata K., et al. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev 2010, 19:150-157.
22. Fletcher M.J., Upton J., Taylor-Fishwick J., et al. COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health 2011, 11:612.
23. Siroux V., Boudier A., Anto J.M., et al. Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy 2008, 63:547.
24. Ma W., Yu L., Wang Y., et al. Changes in health-related quality of life and clinical implications in Chinese patients with chronic cough. Cough 2009, 5:7.
25. French C.L., Irwin R.S., Curley F.J., Krikorian C.J. Impact of chronic cough on quality of life. Arch Intern Med 1998, 158:1657-1661.
26. Wang D.Y., Ghoshal A.G., Razak Bin Abdul M.A., et al. Cough as a key symptom in asthma, allergic rhinitis, COPD and rhinosinusitis and its impact in Asia. Value Health 2014, 17:A776-A777.